MaaT Pharma SA (EPA:MAAT)

MaaT Pharma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	17.1	24.87	20.15	24.28	35.25	43.31
Short-Term Investments	-	-	-	-	0.06	-
Cash & Short-Term Investments	17.1	24.87	20.15	24.28	35.31	43.31
Cash Growth	13.74%	23.39%	-16.99%	-31.24%	-18.46%	117.47%
Accounts Receivable	6.12	5.19	5.03	5.16	4.24	2.39
Other Receivables	1.21	1.63	1.12	1.04	0.78	0.98
Receivables	7.33	6.82	6.15	6.21	5.02	3.37
Inventory	-	0.08	0.06	0.19	0.05	0.03
Prepaid Expenses	1.07	1.05	1.07	1.13	1.58	0.43
Other Current Assets	0.86	0.18	0.21	0.19	0.16	0.13
Total Current Assets	26.35	32.99	27.64	31.99	42.12	47.27
Property, Plant & Equipment	6.59	7.34	8.6	9.17	0.97	1.11
Long-Term Investments	-	-	-	-	-	0.1
Other Intangible Assets	0.87	1.84	1.77	1.34	1.2	0.81
Long-Term Deferred Charges	-	2	-	-	-	-
Other Long-Term Assets	-	-	0.2	0.2	0.3	-
Total Assets	34.19	44.55	38.5	42.93	44.73	49.42

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	12.56	11.81	8.83	6.35	4.51	2.47
Accrued Expenses	2.21	1.86	1.99	1.29	1.24	0.69
Current Portion of Long-Term Debt	3.69	1.16	1.85	2.22	2.77	1.06
Current Portion of Leases	-	1.34	1.28	1.23	0.21	0.19
Current Income Taxes Payable	0.1	0.08	0.09	0.06	0.05	0.03
Current Unearned Revenue	0.24	0.21	-	-	-	-
Other Current Liabilities	0.55	0.52	0.53	0.37	0.44	0.25
Total Current Liabilities	19.36	16.98	14.56	11.52	9.22	4.7
Long-Term Debt	15.59	11.26	8.11	5.75	7.94	3.98
Long-Term Leases	4.49	3.69	4.72	4.88	0.43	0.57
Pension & Post-Retirement Benefits	0.26	0.21	0.17	0.17	0.1	0.12
Other Long-Term Liabilities	10.71	10.62	0.6	0.15	0.23	0.19
Total Liabilities	50.41	42.75	28.17	22.47	17.92	9.56

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1.89	1.89	1.4	1.16	0.99	0.99
Additional Paid-In Capital	0.12	28.77	35.48	37.38	38.32	46.46
Retained Earnings	-18	-28.65	-26.3	-17.86	-12.37	-7.6
Treasury Stock	-0.23	-0.21	-0.23	-0.22	-0.14	-
Comprehensive Income & Other	-0	-	-	-	-	-
Shareholders' Equity	-16.22	1.8	10.34	20.47	26.81	39.86
Total Liabilities & Equity	34.19	44.55	38.5	42.93	44.73	49.42

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	23.78	17.44	15.96	14.08	11.36	5.81
Net Cash (Debt)	-6.67	7.43	4.2	10.21	23.95	37.5
Net Cash Growth	-	76.96%	-58.87%	-57.39%	-36.13%	171.00%
Net Cash Per Share	-0.37	0.47	0.32	0.90	2.42	15.45
Filing Date Shares Outstanding	18.85	18.84	16.08	11.6	11.54	9.89
Total Common Shares Outstanding	18.85	18.82	13.95	11.59	9.94	9.88
Working Capital	7	16.02	13.08	20.47	32.91	42.57
Book Value Per Share	-0.86	0.10	0.74	1.77	2.70	4.03
Tangible Book Value	-17.1	-0.05	8.57	19.12	25.61	39.05
Tangible Book Value Per Share	-0.91	-0.00	0.61	1.65	2.58	3.95
Machinery	1.19	1.11	1.35	1.24	0.99	0.73
Construction In Progress	0.72	0.74	0.56	0.52	0.07	-

Data Source: S&P Global Market Intelligence Last updated: Sep 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 20, 2026

Data Sources Report a data error